Inovio Pharmaceuticals(us:INO)

    1.78

    -3.26%

    Updated on 2024-12-23

    Open:1.82
    Close:1.78
    High:1.83
    Low:1.76
    Pre Close:1.84
    Volume:507481.00
    Amount:913676.94
    Turnover:1.41%
    Shares:36.10M
    MarketCap:64.44M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-30114803703630.96%272240
    2024-03-31131405853017.37%261872
    2023-12-3113644880461.64%152856
    2023-09-3014656888582.11%152368
    2023-06-301937160996026.71%2326107
    2023-03-3120012149509646.24%244681
    2022-12-3120712728506850.29%305872
    2022-09-3020311585473046.44%245666
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Vanguard Group Inc15943856.82%-52721-3.20%
    2024-03-31Renaissance Technologies Llc4502661.93%-157825-25.95%
    2024-03-31Blackrock Inc.3396861.45%119853.66%
    2024-03-31Millennium Management Llc2678021.15%232710663.14%
    2024-03-31Geode Capital Management, Llc2526031.08%133255.57%
    2024-03-31Susquehanna Fundamental Investments, Llc1067910.46%106791
    2024-03-31State Street Corp886810.38%1609722.18%
    2024-03-31Gsa Capital Partners Llp799790.34%-236386-74.72%
    2024-03-31Qube Research & Technologies Ltd777030.33%77703
    2024-03-31Hrt Financial Lp766950.33%64976554.45%

    About

    Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
    Address:660 West Germantown Pike,Suite 110

    Market Movers